• Explore /
  • Poster
  • / <span>ERBB2 mRNA expression to distinguish HER2-low/neg breast cancer prognosis.</span>

ERBB2 mRNA expression to distinguish HER2-low/neg breast cancer prognosis.

Abstract Poster

Authors

null

Yueping Liu

Department of Pathology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China

Yueping Liu , Hong Lv , Mengjia Shen , Ruohong Shui , Feng Ye , Yue Meng , Ying Jia , Chao Liu , Shun An , Xiaoying Yuan , Xingmin Li , Wentao Yang , Hong Bu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Biologic Correlates

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 569)

DOI

10.1200/JCO.2023.41.16_suppl.569

Abstract #

569

Poster Bd #

399

Abstract Disclosures

Similar Posters

First Author: Sung Gwe Ahn

First Author: Sylvie Giacchetti

Poster

2023 ASCO Annual Meeting

<span>AI-based HER2-low IHC scoring in breast cancer across multiple sites, clones, and scanners.</span>

AI-based HER2-low IHC scoring in breast cancer across multiple sites, clones, and scanners.

First Author: Patrick Frey

First Author: Mairi Lucas